Highly lauded drug assessment program under attack

A Silversides - 2008 - Can Med Assoc
Faced with a growing shortage of medical professionals, the Alberta government is
spending $1.4 million over 3 years on groundbreaking programs designed to get more …

The need for greater involvement of regulatory agencies in assessing adverse drug reactions

AD Sniderman - CMAJ, 2000 - Can Med Assoc
Allan D. Sniderman rapid and cannot be sustained will add to the problem rather than solve
it. Indeed, all that is requested is that regulatory agencies apply the same thoroughness in …

Adverse drug reaction reporting controversy

WC Appel - CMAJ, 2002 - Can Med Assoc
The Canadian Institute for Health Information (CIHI) recently reported that Quebec shows a
net loss in the interprovincial migration of physicians, 1 and this poor performance is …

Former director general: Health Canada needs broader drug safety powers

A Silversides - 2006 - Can Med Assoc
News impact of drugs on patients.“Governments have walked away from drug development
and left this to the commercial sector,” he said. But by promoting data linkage and drug …

Review and critique of the Institute of Medicine report “The Future of Drug Safety”

LZ Benet - Clinical Pharmacology & Therapeutics, 2007 - Wiley Online Library
In September 2006 an Institute of Medicine (IOM) ad hoc committee on the Assessment of
the US Drug Safety System released its report entitled “The Future of Drug Safety: Promoting …

Health Canada's investment in new post-market drug surveillance network a “pittance”

A Silversides - 2008 - Can Med Assoc
413 tazone] Avandia,” he says.“You need a system that is capable of detecting an increase
in adverse reactions that are not, like sudden fatal liver disease, well recognized,” he says …

New directions in drug approval

J Lexchin - CMAJ, 2004 - Can Med Assoc
Carole Lalonde user charges paid for close to 50% of the overall cost of running the drug
regulatory system. 8 Bill C-212 was introduced as a private member's bill by Liberal Member …

The Pharmaceutical Medicine Year That Was: A View from San Diego, California, at the End of 2007

AW Fox - International Journal of Pharmaceutical Medicine, 2007 - Springer
The appointment of someone who is a rare combination of clinigenerally not shared by
those who have had the experience of cian, academic, and Washington insider was warmly …

Drug approval system questioned in US and Canada

L Eggertson - CMAJ, 2005 - Can Med Assoc
“There are serious problems in both the review function… and also in the postmarket
surveillance process.” Subsequent to Graham's testimony, a survey of almost 400 FDA …

Can Health Canada protect Canadians from unsafe drugs?

PC Hébert, MB Stanbrook, N MacDonald, K Flegel… - CMAJ, 2011 - Can Med Assoc
Governments have promised to modernize Canada's antiquated laws governing therapeutic
drugs since 1995—only to balk on the threshold of change, at best tinkering around its …